Shattuck Labs Inc (STTK)
3.73
+0.02
(+0.54%)
USD |
NASDAQ |
Sep 20, 16:00
3.73
0.00 (0.00%)
After-Hours: 19:52
Shattuck Labs Profit Margin (Quarterly): -1.34K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.34K% |
| March 31, 2024 | -1.66K% |
| December 31, 2023 | -2.48K% |
| September 30, 2023 | -4.01K% |
| June 30, 2023 | -10.67K% |
| March 31, 2023 | -36.36K% |
| December 31, 2022 | -6.52K% |
| September 30, 2022 | -11.62K% |
| June 30, 2022 | -54.74K% |
| March 31, 2022 |
| Date | Value |
|---|---|
| December 31, 2021 | 26.09% |
| September 30, 2021 | -916.3% |
| June 30, 2021 | |
| March 31, 2021 | -520.4% |
| December 31, 2020 | -895.1% |
| September 30, 2020 | -485.8% |
| June 30, 2020 | -195.2% |
| March 31, 2020 | -220.2% |
| December 31, 2019 | -261.2% |
| September 30, 2019 | -408.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-54.74K%
Minimum
Jun 2022
26.09%
Maximum
Dec 2021
-7.40K%
Average
-1.13K%
Median
Profit Margin (Quarterly) Benchmarks
| Kymera Therapeutics Inc | -164.0% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
| NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.11% |
| Return on Assets | -59.21% |
| Return on Invested Capital | -67.11% |
| Operating Margin (Quarterly) | -1.43K% |
| Return on Net Operating Assets | -576.7% |